最高法院擴大快速消費品藐視法庭案件範圍以解決欺騙性廣告行為

最高法院將對誤導性廣告的審查範圍擴大到 Patanjali Ayurved 以外的所有快速消費品 (FMCG) 公司。法院認識到對公共利益的更廣泛影響，關注範圍擴大到所有發布欺騙性主張的實體。在帕坦賈利藐視法庭案的聽證會上，法院質疑該公司公開道歉的誠意，並指示中央部會提供政府針對誤導性廣告所採取行動的詳細資訊。

Supreme Court Expands Scope of Patanjali Contempt Case to Tackle Misleading FMCG Advertisements

最高法院擴大帕坦賈利藐視法庭案的範圍以解決誤導性快速消費品廣告

New Delhi, India: In a landmark ruling, the Supreme Court of India today sent shockwaves through the country's Fast-Moving Consumer Goods (FMCG) industry. The Court clarified that its contempt proceedings against Patanjali Ayurved, triggered by the company's deceptive advertising practices, are not solely focused on Patanjali as an isolated entity. Rather, the Court's mandate extends to the entire realm of FMCG companies that persistently publish misleading advertisements, a practice that has become rampant in recent years.

印度新德里：印度最高法院今天做出了一項具有里程碑意義的裁決，震驚了該國的快速消費品 (FMCG) 行業。法院澄清，由於 Patanjali Ayurved 公司的欺騙性廣告行為而引發的藐視法庭訴訟不僅僅針對 Patanjali 作為一個孤立的實體。相反，法院的授權範圍涵蓋了持續發布誤導性廣告的整個快速消費品公司，這種做法近年來變得猖獗。

The Court, presided over by a three-judge bench, grilled Baba Ramdev and Acharya Balkrishna, the enigmatic duo behind Patanjali Ayurved, questioning the sincerity of their recent public apology published in newspapers. The bench pointedly asked if the apology was of comparable size and cost to the sprawling front-page advertisements the company regularly employs to promote its herbal remedies.

法庭由三名法官主持，對帕坦賈利·阿育維背後的神秘二人組巴巴·拉姆德夫和阿查里亞·巴爾克里希納進行了質問，質疑他們最近在報紙上發表的公開道歉的誠意。法官們尖銳地詢問，這次道歉的規模和成本是否與該公司經常使用的大量頭版廣告來宣傳其草藥療法相當。

The Court's scrutiny extended beyond Patanjali. It issued a stern warning to the petitioner, the Indian Medical Association (IMA), expressing concern over allegations of unethical practices within the allopathic medical community. The judges emphasized the need for fair and unbiased practices across the entire healthcare sector.

法院的審查範圍超出了帕坦賈利的範圍。它向請願者印度醫學協會（IMA）發出嚴厲警告，對對抗療法醫學界的不道德行為指控表示擔憂。法官們強調整個醫療保健產業需要公平和公正的做法。

Expanding the scope of the case, the Supreme Court instructed central government ministries to submit detailed affidavits outlining their actions over the past three years to curb misleading advertisements. This unprecedented move signals the Court's determination to address the pervasive issue of false and deceptive marketing claims that harm consumers and erode public trust.

為了擴大案件範圍，最高法院指示中央政府各部會提交詳細的宣誓書，概述他們在過去三年中遏制誤導性廣告的行動。這項史無前例的舉措標誌著法院決心解決損害消費者和削弱公眾信任的虛假和欺騙性行銷主張這一普遍存在的問題。

The IMA had initiated contempt proceedings against Patanjali Ayurved after the company published a series of advertisements that allegedly made extravagant claims of curing various diseases and subtly disparaged modern medicine. The IMA, an umbrella organization representing over 2.5 lakh doctors in India, has been a vocal critic of Patanjali's advertising practices, accusing the company of misleading the public and undermining the reputation of allopathic medicine.

在Patanjali Ayurved公司發布了一系列廣告，據稱這些廣告誇大地聲稱可以治愈多種疾病並巧妙地貶低現代醫學後，IMA對Patanjali Ayurved提起了藐視法庭訴訟。 IMA 是代表印度超過 25 萬名醫生的傘式組織，一直直言不諱地批評 Patanjali 的廣告做法，指責該公司誤導公眾並損害了對抗療法的聲譽。

The Supreme Court's momentous ruling has sent a clear message to FMCG companies: the era of unbridled false advertising is over. The Court's resolve to protect consumers from misleading claims and ensure fair competition within the healthcare sector has set a groundbreaking precedent that is expected to shape the industry landscape in the years to come.

最高法院的重大判決向快消品企業發出了明確的訊息：肆無忌憚的虛假廣告時代已經結束。法院決心保護消費者免受誤導性主張並確保醫療保健行業內的公平競爭，這樹立了開創性的先例，預計將在未來幾年塑造行業格局。